ARCHIVES

MGMT Gene Can Determine Disease Aggressiveness

This article is from The Cancer Letter archive.

Vol. 34 No. 6 | June 24, 2011

Download PDF Visit The Full Archive

Related Articles

Abraxane Improves Progression-Free Survival Compared to Decarbazine In Stage IV Disease

November 30, 2012

NCI Advisory Group, Other Cancer Meetings

January 2, 1981

Sanofi: Zaltrap Price Reflects Competing Drugs In Second-Line Metastatic Colon Cancer

November 1, 2012

ACS Reorganization Plans, Policy Changes Discussed By Board

November 29, 1991

Agricultural Pesticide Use Linked To Prostate Cancer

July 25, 2003

Anonymous $100 Million Gift Moves OHSU Within $82 Million Of Reaching $1 Billion Goal

August 1, 2014